Minoo Battiwalla

7.7k total citations
142 papers, 2.6k citations indexed

About

Minoo Battiwalla is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Minoo Battiwalla has authored 142 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Hematology, 54 papers in Oncology and 40 papers in Immunology. Recurrent topics in Minoo Battiwalla's work include Hematopoietic Stem Cell Transplantation (60 papers), Immune Cell Function and Interaction (28 papers) and CAR-T cell therapy research (27 papers). Minoo Battiwalla is often cited by papers focused on Hematopoietic Stem Cell Transplantation (60 papers), Immune Cell Function and Interaction (28 papers) and CAR-T cell therapy research (27 papers). Minoo Battiwalla collaborates with scholars based in United States, United Kingdom and Canada. Minoo Battiwalla's co-authors include A. John Barrett, Peiman Hematti, Sawa Ito, Philip L. McCarthy, Nikolaos G. Almyroudis, A. John Barrett, Brahm H. Segal, T. J. Walsh, Theresa Hahn and Nancy F. Hensel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Neurology.

In The Last Decade

Minoo Battiwalla

131 papers receiving 2.6k citations

Peers

Minoo Battiwalla
Isidro Jarque Spain
Shelly L. Carter United States
Filippo Milano United States
Voravit Ratanatharathorn United States
Neena Kapoor United States
R. Champlin United States
Peter Bardy Australia
Jaime Sanz Spain
Carmella van de Ven United States
Ahmet Elmaağaclı Germany
Isidro Jarque Spain
Minoo Battiwalla
Citations per year, relative to Minoo Battiwalla Minoo Battiwalla (= 1×) peers Isidro Jarque

Countries citing papers authored by Minoo Battiwalla

Since Specialization
Citations

This map shows the geographic impact of Minoo Battiwalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minoo Battiwalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minoo Battiwalla more than expected).

Fields of papers citing papers by Minoo Battiwalla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minoo Battiwalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minoo Battiwalla. The network helps show where Minoo Battiwalla may publish in the future.

Co-authorship network of co-authors of Minoo Battiwalla

This figure shows the co-authorship network connecting the top 25 collaborators of Minoo Battiwalla. A scholar is included among the top collaborators of Minoo Battiwalla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minoo Battiwalla. Minoo Battiwalla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Martin, Casey, Betsy Blunk, Sarah T. Garber, et al.. (2025). Remote Patient Monitoring for 15 Vs. 30 Days in Outpatient Chimeric Antigen Receptor T-Cell Therapy (CAR-T) across a Large Health System. Transplantation and Cellular Therapy. 31(2). S223–S224.
3.
Majhail, Navneet S., Minoo Battiwalla, Aravind Ramakrishnan, et al.. (2025). Outpatient Administration of Chimeric Antigen Receptor T-Cell Therapy Using Remote Patient Monitoring. JCO Oncology Practice. 21(11). 1601–1608. 1 indexed citations
4.
5.
Martin, Casey, Betsy Blunk, Aravind Ramakrishnan, et al.. (2024). Comparison of 15- Vs. 30-Day Remote Patient Monitoring for Outpatient Chimeric Antigen Receptor T-Cell Therapy (CAR-T) across a Large Health System. Blood. 144(Supplement 1). 2300–2300. 1 indexed citations
6.
Battiwalla, Minoo, Michael Tees, Ian W. Flinn, et al.. (2024). Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy network. Blood Advances. 9(2). 429–435. 4 indexed citations
7.
Battiwalla, Minoo, José C. Cruz, William B. Donnellan, et al.. (2024). Determinants of Outcomes for Acute Myeloid Leukemia Patients Treated in a Community-Based Specialized Versus Non-Specialized Hospital Setting. PubMed. 6(4). 43–52. 1 indexed citations
8.
Üstün, Celalettin, Min Chen, Soyoung Kim, et al.. (2023). Post-transplantation cyclophosphamide is associated with increased bacterial infections. Bone Marrow Transplantation. 59(1). 76–84. 4 indexed citations
9.
Murphy, Jeanne, et al.. (2019). A Practical Guide to Gynecologic and Reproductive Health in Women Undergoing Hematopoietic Stem Cell Transplant. Biology of Blood and Marrow Transplantation. 25(11). e331–e343. 11 indexed citations
10.
Duncan, Christine, Ruta Brazauskas, Jiaxing Huang, et al.. (2018). Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 53(10). 1278–1287. 27 indexed citations
11.
12.
Battiwalla, Minoo, André Tichelli, & Navneet S. Majhail. (2017). Reprint of: Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care. Biology of Blood and Marrow Transplantation. 23(3). S1–S9. 8 indexed citations
13.
Tian, Xin, Neil Dunavin, Nancy F. Hensel, et al.. (2016). Improved reproducibility and quality of GvHD biomarker assay: application of multiplex microfluidic channel system. Bone Marrow Transplantation. 51(12). 1615–1616.
14.
Armenian, Saro H., Wassim Chemaitilly, Marcus Y. Chen, et al.. (2016). National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report. Biology of Blood and Marrow Transplantation. 23(2). 201–210. 64 indexed citations
15.
Dumitriu, Bogdan, Sawa Ito, Xingmin Feng, et al.. (2015). Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study. The Lancet Haematology. 3(1). e22–e29. 39 indexed citations
16.
Dunavin, Neil, Christopher S. Hourigan, Robert Q. Le, et al.. (2015). CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation. Supportive Care in Cancer. 24(2). 815–822. 5 indexed citations
17.
Gress, Ronald E., Jeffrey S. Miller, Minoo Battiwalla, et al.. (2013). Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part I. Biology of Relapse after Transplantation. Biology of Blood and Marrow Transplantation. 19(11). 1537–1545. 22 indexed citations
18.
Battiwalla, Minoo, David F. Stroncek, Deborah E. Citrin, et al.. (2012). Outcomes After CD34+ Selection With or Without the Addition of Photo-Allodepleted T Lymphocytes in Myeloablative HLA-Matched Sibling Transplantation. Biology of Blood and Marrow Transplantation. 18(2). S260–S260. 1 indexed citations
19.
Mielke, Stephan, Aarthi Shenoy, Vicki Fellowes, et al.. (2011). Selectively T Cell-Depleted Allografts from HLA-Matched Sibling Donors Followed by Low-Dose Posttransplantation Immunosuppression to Improve Transplantation Outcome in Patients with Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 17(12). 1855–1861. 34 indexed citations
20.
Battiwalla, Minoo, Yiyuan Wu, Rajinder Bajwa, et al.. (2007). Ganciclovir Inhibits Lymphocyte Proliferation by Impairing DNA Synthesis. Biology of Blood and Marrow Transplantation. 13(7). 765–770. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isidro Jarque Breakdown of academic impact, for papers by Shelly L. Carter Breakdown of academic impact, for papers by Filippo Milano Breakdown of academic impact, for papers by Voravit Ratanatharathorn Breakdown of academic impact, for papers by Neena Kapoor Breakdown of academic impact, for papers by R. Champlin Breakdown of academic impact, for papers by Peter Bardy Breakdown of academic impact, for papers by Jaime Sanz Breakdown of academic impact, for papers by Carmella van de Ven Breakdown of academic impact, for papers by Ahmet Elmaağaclı
Rankless by CCL
2026